A Clinical Study of GO321 in Patients With Advanced Solid Tumors

NCT07748117 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor Malignancies

Interventions

DRUG: GO321

Sponsor

GeneSail Biotech (Shanghai) Co., Ltd.